BIOMAT Database Logo BIOMAT Database Logo

[Oral and parenteral iron therapy]. 1970

W Pribilla

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007505 Iron-Dextran Complex A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292) Dextran-Iron Complex,Dexferrum,Dextrofer,Feosol,Ferridextran,Hematran,Icar,Imfergen,Imferon,Imperon,Imposil,InFed,Norferan,Dextran Iron Complex,Iron Dextran Complex
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000747 Anemia, Hypochromic Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) Chlorosis,Anemias, Hypochromic,Chloroses,Hypochromic Anemia,Hypochromic Anemias
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

W Pribilla
ORAL AND PARENTERAL IRON THERAPY: A COMPARISON.
March 1965, JAMA,
W Pribilla
[Rational iron therapy: oral or parenteral].
July 1955, Wiener medizinische Wochenschrift (1946),
W Pribilla
Oral and parenteral iron.
March 1969, The Medical letter on drugs and therapeutics,
W Pribilla
Oral or parenteral iron therapy in haemodialysis patients?
January 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
W Pribilla
[Parenteral iron therapy].
June 1969, Kinderarztliche Praxis,
W Pribilla
Parenteral iron therapy.
January 1989, M.D. computing : computers in medical practice,
W Pribilla
Parenteral iron therapy.
May 2008, The Israel Medical Association journal : IMAJ,
W Pribilla
Parenteral iron therapy.
January 1968, Scottish medical journal,
W Pribilla
[PARENTERAL IRON THERAPY].
January 1964, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
W Pribilla
[PARENTERAL IRON THERAPY].
January 1964, Gazeta medica portuguesa,
Copied contents to your clipboard!